Kazufumi Nakamura Selected Research

Kazufumi Nakamura Research Topics

Disease

17	Heart Failure 03/2022 - 06/2002
16	Pulmonary Arterial Hypertension 01/2021 - 12/2009
11	Coronary Artery Disease (Coronary Atherosclerosis) 04/2019 - 05/2011
11	Familial Primary Pulmonary Hypertension 07/2013 - 09/2004
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2006
9	Pulmonary Hypertension 01/2021 - 11/2004
9	Brugada Syndrome 12/2017 - 06/2002
8	Atherosclerosis 01/2022 - 07/2004
8	Hypertension (High Blood Pressure) 11/2021 - 09/2004
7	Atrial Fibrillation 11/2021 - 01/2003
7	Inflammation (Inflammations) 10/2018 - 01/2003
6	Cardiac Arrhythmias (Arrythmia) 12/2021 - 11/2003
6	Left Ventricular Dysfunction 01/2021 - 11/2008
6	Hypertrophy 05/2019 - 08/2011
6	Body Weight (Weight, Body) 05/2019 - 06/2002
6	Ventricular Fibrillation 05/2019 - 01/2008
6	Sarcoidosis (Schaumann Disease) 10/2018 - 10/2007
5	Myocardial Infarction 02/2022 - 11/2011
5	Type 2 Diabetes Mellitus (MODY) 02/2022 - 07/2014
5	Fibrosis (Cirrhosis) 01/2021 - 02/2014
5	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2005
5	Chronic Renal Insufficiency 09/2018 - 01/2011
5	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2017 - 06/2002
5	Long QT Syndrome 06/2017 - 02/2003
4	Insulin Resistance 03/2022 - 04/2014
4	Amyloidosis 12/2021 - 12/2019
4	Cardiomegaly (Heart Hypertrophy) 05/2019 - 12/2003
4	Hemorrhage 04/2019 - 02/2005
4	Ventricular Tachycardia 08/2017 - 11/2003
4	Ischemia 06/2017 - 11/2011
4	Hyperlipidemias (Hyperlipidemia) 04/2016 - 08/2011
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2022 - 06/2005
3	Diabetes Mellitus 01/2022 - 06/2018
3	Hypercholesterolemia 01/2022 - 01/2018
3	Cardiotoxicity 01/2022 - 01/2021
3	Stable Angina 02/2021 - 03/2014
3	Myocarditis (Carditis) 01/2021 - 01/2021
3	Heart Diseases (Heart Disease) 01/2021 - 07/2013
3	Infections 08/2019 - 02/2018
3	Shock 08/2017 - 11/2010
3	Hypoxia (Hypoxemia) 04/2017 - 01/2016
3	Hypertriglyceridemia 04/2016 - 08/2011
3	Catheter-Related Infections 04/2016 - 01/2015
3	Thrombosis (Thrombus) 01/2013 - 05/2002
2	Pathologic Constriction (Stenosis) 02/2022 - 01/2021
2	Death (Near-Death Experience) 01/2022 - 01/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 04/2014

Drug/Important Bio-Agent (IBA)

10	Epoprostenol (Prostacyclin)FDA LinkGeneric 11/2019 - 02/2005
9	Pharmaceutical PreparationsIBA 01/2021 - 06/2002
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 08/2011
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 11/2008
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2011
5	voglibose (Basen)IBA 01/2022 - 07/2014
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2002
5	MonocrotalineIBA 01/2021 - 05/2015
5	Eicosapentaenoic AcidIBA 06/2018 - 10/2014
4	Sodium-Glucose Transport ProteinsIBA 03/2022 - 01/2019
4	Nicorandil (SG 75)IBA 02/2021 - 06/2017
4	LipidsIBA 01/2020 - 08/2011
4	Angiotensin Receptor AntagonistsIBA 01/2019 - 10/2009
4	Cystatin CIBA 09/2018 - 07/2013
4	Carvedilol (Coreg)FDA LinkGeneric 08/2011 - 06/2002
4	Anti-Arrhythmia AgentsIBA 08/2007 - 06/2002
3	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2022 - 01/2019
3	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2022 - 01/2019
3	Bisoprolol (Concor)FDA LinkGeneric 11/2021 - 08/2011
3	CalciumIBA 01/2021 - 10/2009
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 10/2014
3	pitavastatin (itavastatin)FDA Link 01/2020 - 01/2018
3	LDL CholesterolIBA 01/2020 - 10/2014
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2019 - 07/2006
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019 - 09/2004
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 09/2004
3	Glycoside Hydrolase InhibitorsIBA 01/2019 - 07/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018 - 10/2007
3	Imatinib Mesylate (Gleevec)FDA Link 04/2017 - 08/2012
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 10/2014
3	SteroidsIBA 05/2015 - 09/2014
3	Ezetimibe (Zetia)FDA Link 10/2014 - 08/2011
3	Ion Channels (Ion Channel)IBA 12/2012 - 06/2004
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2009 - 07/2004
3	Sodium Channel BlockersIBA 04/2009 - 11/2003
3	pilsicainideIBA 05/2008 - 11/2003
3	Epinephrine (Adrenaline)FDA LinkGeneric 09/2004 - 06/2002
2	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2022
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2019
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2013
2	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 01/2019
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2019
2	AntioxidantsIBA 01/2022 - 08/2006
2	DiureticsIBA 01/2022 - 01/2017

Therapy/Procedure

32	Therapeutics 01/2022 - 02/2005
12	Percutaneous Coronary Intervention 02/2022 - 11/2011
8	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2017 - 05/2006
7	Lung Transplantation 08/2017 - 09/2004
3	Catheter Ablation 11/2019 - 04/2019
3	Liver Transplantation 10/2019 - 01/2015
2	Stents 02/2022 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Length of Stay 01/2022 - 08/2019